Rafarma Pharmaceuticals, Inc. (RAFA)

OTCMKTS · Delayed Price · Currency is USD
0.0700
-0.0050 (-6.67%)
Mar 6, 2026, 3:00 PM EST
-55.13%
Market Cap 6.10M
Revenue (ttm) 133.33K
Net Income (ttm) -117.22K
Shares Out 87.77M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,800
Average Volume 32,529
Open 0.0700
Previous Close 0.0750
Day's Range 0.0700 - 0.0700
52-Week Range 0.0036 - 0.1779
Beta 0.54
RSI 55.54
Earnings Date n/a

About Rafarma Pharmaceuticals

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture t... [Read more]

Sector Healthcare
Country United States
Stock Exchange OTCMKTS
Ticker Symbol RAFA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.